Structural heart cases
Evolut-R CoreValve TAVR case with difficult vascular access via percutaneous femoral approach utilizing Shockwave Lithotripsy – September 2019

Case and Plan:
91-year-old female with hypertension, hypothyroid and chronic diastolic heart failure (HFpEF) presents with progressive exertional dyspnea and NYHA CCS Class III for the past few weeks. She also had a recent hospitalization at OSH for flash pulmonary edema and heart failure exacerbation requiring IV diuretics and thoracentesis. Echo revealed severe calcified aortic valve stenosis with AVA/PG/MG/PV of 0.6/72/49/4.2 with EF of 60%. Recent angiogram revealed non-obstructive CAD. The aortic annulus measured 19.5 x 25.6 mm (mean 22.6 mm), annular perimeter was 72.6 mm and the annular area was 406.4 mm2. The STS mortality risk for surgical AVR was 3.73% and the logistic Euroscore mortality risk was 15.2. The patient underwent Heart Team evaluation and was found to be at high risk for SAVR due to comorbidities, advanced age and frailty. Analysis of lower extremity on CT angiogram revealed severe calcified peripheral arterial disease with tortuosity not adequate diameter for trans-femoral approach. The dimensions of the right common femoral artery and right external iliac arteries were less than 5.5mm. So, patient now presents for TAVR with 26 mm Evolut-R CoreValve via a right femoral percutaneous approach with extracorporeal shockwave lithotripsy (ESWL) of right iliac artery and possible Sentinel cerebral protection device.

comments

Join the Discussion

2 thoughts on “Evolut-R CoreValve TAVR case with difficult vascular access via percutaneous femoral approach utilizing Shockwave Lithotripsy – September 2019”

  1. Shreeram kannan says:

    couple of questions on alternate access:
    1. How about highly tortuous iliofemoral arteries. Is there a way to still navigate around this problem and go ahead with a transfemoral approach ?
    2. Is the profile going to go down further to enable a radial access for TAVR?

  2. Anoop says:

    Can you please walk-through your thought process of selecting a 26 mm Evolut R in this case (vs using an oversized 29 mm)? Thanks


Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Mount Sinai Hospital, One Gustave L. Levy Place, Box, New York, NY, 10029, https://ccclivecases.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

suggestion
Suggestions
Bioprosthetic Aortic ViV TAVR after Valve Fracture and Evolut Pro+ Implantation – November 2020
Views 42

  Case and Plan: 60 year-old male presents with worsening exertional dyspnea (NYHA Class III) and multiple admissions for CHF exacerbation in past 3 months. Past medical history is significant for symptomatic severe aortic insufficiency s/p bioprosthetic AVR (2017) with 23mm Magna 3000 valve, ESRD on HD, HTN and HLD. Recent echocardiogram revealed bioprosthetic valve […]


TF-TAVR with No Contrast – September 2020
Views 149

Case and Plan: 61 year-old-male with ETOH abuse, hepatitis and cirrhosis s/p Liver transplant in 6/2019 at MSH with postop course notable for AKI requiring dialysis (last dialysis 7/6/2019), Hypertension, Anemia, Former smoker, CKD stage III.


59:42
Urgent Appropriately Indicated MitraClip Procedure in Patient with Cardiogenic Shock in Covid-19 Era – May 2020
Views 863

 Case and Plan: 74-year-old male former smoker with PMHx of HTN, HLD, and A Fib (on Eliquis) had IW-STEMI on 02/09/20. Cath showed occluded mRCA with dLM bifurcation disease; S/p DES-PPCI to mRCA. Transthoracic echocardiogram at the time of discharge showed an EF of 55% with moderate MR. Pt had staged PCI to dLM […]


TAVR using Transcarotid Access – March 2020
Tags: |
Views 691

Case and Plan: 73-year-old male with hypertension, hyperlipidemia, parathyroidectomy, renal cell carcinoma s/p nephrectomy and right renal transplant in 2001 on chronic steroids and immunosuppressant therapy, paroxysmal atrial fibrillation on AC with warfarin, chronic diastolic heart failure and severe PAD presents with progressive exertional dyspnea NYHA-Class III for the past month after walking up to […]